Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to ...

A promising biotechnology company developed a new approach that might treat a rare disease — but its sole employee didn’t do ...

CNN sits down with Ester Baiget, CEO of Novonesis, to discuss how biotechnology can boost food production in the Gulf.

Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides ...

Vir Biotechnology (NASDAQ:VIR) said its combination treatment for chronic hepatitis delta met the primary and key secondary ...

Vir Biotechnology (VIR) stock rose 13% to $13.85 after Phase 3 ECLIPSE 1 hepatitis delta results. See the trial data, safety ...

Elebsiran is an investigational hepatitis B virus-targeting small interfering ribonucleic acid (siRNA) licensed from Alnylam ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Vir Biotechnology remains a Buy after flawless Phase 3 ECLIPSE 1 results and a major new Gilead partnership. Read more on VIR ...

Sana Biotechnology, Inc. reported third-quarter 2026 financial results and business updates, highlighting progress toward clinical studies of its engineered cell therapy programs ...

Ended quarter with approximately $901 million in cash, cash equivalents and investments, excluding $90 million in upfront ...